Heidelberg Pharma AG (WL6):企業の財務・戦略的SWOT分析

【英語タイトル】Heidelberg Pharma AG (WL6) - Financial and Strategic SWOT Analysis Review

GlobalDataが出版した調査資料(DATA904C0578)・商品コード:DATA904C0578
・発行会社(調査会社):GlobalData
・発行日:2018年7月
・ページ数:51
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,375見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥26,750見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥40,125見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000を加算
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Heidelberg Pharma AG (WL6) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Heidelberg Pharma AG (Heidelberg Pharma) formerly, Wilex AG is a biopharmaceutical company. The company develops therapeutic and diagnostic product candidates for the treatment and specific detection of various cancers. Heidelberg Pharma’s pipeline products are focused on treating multiple myeloma, prostate cancer, hematological cancers, metastatic pancreatic cancers, leukemia, non- metastatic ccRCC, kidney cancers and solid tumors. Through its subsidiaries it also provides preclinical contract research services and an antibody drug conjugate (ADC) technology platform. Heidelberg Pharma is headquartered in Ladenburg, Germany.

Heidelberg Pharma AG Key Recent Developments

Jul 12,2018: Heidelberg Pharma reports on first half -year
Apr 12,2018: Heidelberg Pharma: Interim Management Statement on the First Three Months of 2018
Apr 09,2018: Heidelberg Pharma Presents Proprietary ATAC Technology Platform at Two Scientific Conferences
Mar 22,2018: Heidelberg Pharma announces financial figures for fiscal year 2017 and provides business update
Jan 08,2018: Heidelberg Pharma and Advanced Proteome Therapeutics Progress Collaborative Program

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 – About the Company 5
Heidelberg Pharma AG – Key Facts 5
Heidelberg Pharma AG – Key Employees 6
Heidelberg Pharma AG – Key Employee Biographies 7
Heidelberg Pharma AG – Major Products and Services 8
Heidelberg Pharma AG – History 9
Heidelberg Pharma AG – Company Statement 12
Heidelberg Pharma AG – Locations And Subsidiaries 14
Head Office 14
Other Locations & Subsidiaries 14
Section 2 – Company Analysis 15
Company Overview 15
Heidelberg Pharma AG – Business Description 16
Heidelberg Pharma AG – Corporate Strategy 17
Heidelberg Pharma AG – SWOT Analysis 18
SWOT Analysis – Overview 18
Heidelberg Pharma AG – Strengths 18
Heidelberg Pharma AG – Weaknesses 19
Heidelberg Pharma AG – Opportunities 20
Heidelberg Pharma AG – Threats 21
Heidelberg Pharma AG – Key Competitors 22
Section 3 – Company Financial Ratios 23
Financial Ratios – Capital Market Ratios 23
Financial Ratios – Annual Ratios 24
Performance Chart 26
Financial Performance 26
Financial Ratios – Interim Ratios 27
Financial Ratios – Ratio Charts 28
Section 4 – Company’s Lifesciences Financial Deals and Alliances 29
Heidelberg Pharma AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 29
Heidelberg Pharma AG, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 30
Heidelberg Pharma AG, Recent Deals Summary 31
Section 5 – Company’s Recent Developments 32
Jul 12, 2018: Heidelberg Pharma reports on first half -year 32
Apr 12, 2018: Heidelberg Pharma: Interim Management Statement on the First Three Months of 2018 34
Apr 09, 2018: Heidelberg Pharma Presents Proprietary ATAC Technology Platform at Two Scientific Conferences 36
Mar 22, 2018: Heidelberg Pharma announces financial figures for fiscal year 2017 and provides business update 37
Jan 08, 2018: Heidelberg Pharma and Advanced Proteome Therapeutics Progress Collaborative Program 40
Jul 13, 2017: WILEX reports on first half-year 41
Apr 12, 2017: WILEX: Interim management statement on the first three months of 2017 43
Mar 30, 2017: WILEX announces financial figures for the 2016 fiscal year and reports on course of business 45
Section 6 – Appendix 47
Methodology 47
Ratio Definitions 47
About GlobalData 51
Contact Us 51
Disclaimer 51

List of Tables
Heidelberg Pharma AG, Key Facts 5
Heidelberg Pharma AG, Key Employees 6
Heidelberg Pharma AG, Key Employee Biographies 7
Heidelberg Pharma AG, Major Products and Services 8
Heidelberg Pharma AG, History 9
Heidelberg Pharma AG, Subsidiaries 14
Heidelberg Pharma AG, Key Competitors 22
Heidelberg Pharma AG, Ratios based on current share price 23
Heidelberg Pharma AG, Annual Ratios 24
Heidelberg Pharma AG, Annual Ratios (Cont...1) 25
Heidelberg Pharma AG, Interim Ratios 27
Heidelberg Pharma AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 29
Heidelberg Pharma AG, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 30
Heidelberg Pharma AG, Recent Deals Summary 31
Currency Codes 47
Capital Market Ratios 47
Equity Ratios 48
Profitability Ratios 48
Cost Ratios 49
Liquidity Ratios 49
Leverage Ratios 50
Efficiency Ratios 50

List of Figures
Heidelberg Pharma AG, Performance Chart (2013 - 2017) 26
Heidelberg Pharma AG, Ratio Charts 28
Heidelberg Pharma AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 29
Heidelberg Pharma AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 30

★調査レポート[Heidelberg Pharma AG (WL6):企業の財務・戦略的SWOT分析] (コード:DATA904C0578)販売に関する免責事項を必ずご確認ください。
★調査レポート[Heidelberg Pharma AG (WL6):企業の財務・戦略的SWOT分析]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆